EGFR and cancer: The KEGG pathway analysis of SchB against SARS-CoV-2_hepatitis demonstrated a correlation with cancer, EGFR tyrosine kinase inhibitor resistance, cell cycle, human papillomavirus infection, HCV infection, and platinum drug resistance (Figure 7A).